Achieved oxygen saturations and risk for bronchopulmonary dysplasia with pulmonary hypertension in preterm infants

被引:1
|
作者
Gentle, Samuel J. [1 ]
Singh, Avinash [2 ]
Travers, Colm P. [1 ]
Nakhmani, Arie [2 ]
Carlo, Waldemar A. [1 ]
Ambalavanan, Namasivayam [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Elect & Comp Engn, Birmingham, AL USA
关键词
Neonatology; Respiratory Medicine; Intensive Care Units; Neonatal; OUTCOMES; DISEASE; ASSOCIATION; MORTALITY; INDEX; HEART;
D O I
10.1136/archdischild-2024-327014
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Characterisation of oxygen saturation (SpO(2))-related predictors that correspond with both bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) development and survival status in infants with BPD-PH may improve patient outcomes. This investigation assessed whether (1) infants with BPD-PH compared with infants with BPD alone, and (2) BPD-PH non-survivors compared with BPD-PH survivors would (a) achieve lower SpO(2) distributions, (b) have a higher fraction of inspired oxygen (FiO(2)) exposure and (c) have a higher oxygen saturation index (OSI). Design Case-control study between infants with BPD-PH (cases) and BPD alone (controls) and by survival status within cases. Setting Single-centre study in the USA. Patients Infants born at <29 weeks' gestation and on respiratory support at 36 weeks' postmenstrual age. Exposures FiO(2) exposure, SpO(2) distributions and OSI were analysed over the week preceding BPD-PH diagnosis. Main outcomes and measures BPD-PH, BPD alone and survival status in infants with BPD-PH. Results 40 infants with BPD-PH were compared with 40 infants with BPD alone. Infants who developed BPD-PH achieved lower SpO(2) compared with infants with BPD (p<0.001), were exposed to a higher FiO(2) (0.50 vs 0.34; p=0.02) and had a higher OSI (4.3 vs 2.6; p=0.03). Compared with survivors, infants with BPD-PH who died achieved a lower SpO(2) (p<0.001) and were exposed to a higher FiO(2) (0.70 vs 0.42; p=0.049). Conclusions SpO(2)-related predictors differed between infants with BPD-PH and BPD alone and among infants with BPD-PH by survival status. The OSI may provide a non-invasive predictor for BPD-PH in preterm infants.
引用
收藏
页码:941 / 947
页数:7
相关论文
共 50 条
  • [31] Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
    Sudip Sheth
    Lisa Goto
    Vineet Bhandari
    Boban Abraham
    Anja Mowes
    Journal of Perinatology, 2020, 40 : 138 - 148
  • [32] Mortality in preterm infants with bronchopulmonary dysplasia associated pulmonary hypertension: A systematic literature review
    Downham, Laura
    Cerovic, Sofija
    Lesage, Catherine
    Leroy, Sandrine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 99 - 100
  • [33] The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year
    Lagatta, Joanne M.
    Hysinger, Erik B.
    Zaniletti, Isabella
    Wymore, Erica M.
    Vyas-Read, Shilpa
    Yallapragada, Sushmita
    Nelin, Leif D.
    Truog, William E.
    Padula, Michael A.
    Porta, Nicolas F. M.
    Savani, Rashmin C.
    Potoka, Karin P.
    Kawut, Steven M.
    DiGeronimo, Robert
    Natarajan, Girija
    Zhang, Huayan
    Grover, Theresa R.
    Engle, William A.
    Murthy, Karna
    JOURNAL OF PEDIATRICS, 2018, 203 : 218 - +
  • [34] NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
    Dasgupta, Soham
    Aly, Ashraf M.
    Malloy, Michael H.
    Okorodudu, Anthony O.
    Jain, Sunil K.
    JOURNAL OF PERINATOLOGY, 2018, 38 (09) : 1252 - 1257
  • [35] NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
    Soham Dasgupta
    Ashraf M. Aly
    Michael H. Malloy
    Anthony O. Okorodudu
    Sunil K. Jain
    Journal of Perinatology, 2018, 38 : 1252 - 1257
  • [36] Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
    Sheth, Sudip
    Goto, Lisa
    Bhandari, Vineet
    Abraham, Boban
    Mowes, Anja
    JOURNAL OF PERINATOLOGY, 2020, 40 (01) : 138 - 148
  • [37] Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study
    Siddaiah, Roopa
    Oji-Mmuo, Christiana
    Aluquin, Vincent P. R.
    Kawasawa, Yuka Imamura
    Donnelly, Ann
    Rousselle, Dustin
    Fuentes, Nathalie
    Austin, Eric D. D.
    Silveyra, Patricia
    PULMONARY CIRCULATION, 2023, 13 (02)
  • [38] DEXAMETHASONE TREATMENT IN PRETERM INFANTS AT RISK FOR BRONCHOPULMONARY DYSPLASIA
    KARI, MA
    HEINONEN, K
    IKONEN, RS
    KOIVISTO, M
    RAIVIO, KO
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1993, 68 (05): : 566 - 569
  • [39] Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
    Su, Ya-Ting
    Chiu, Chun-Che
    Lai, Shen-Hao
    Hsia, Shao-Hsuan
    Lin, Jainn-Jim
    Chan, Oi-Wa
    Chiu, Chih-Yung
    Tseng, Pei-Ling
    Lee, En-Pei
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [40] Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants
    Joyce E. O’Shea
    Peter G. Davis
    Lex W. Doyle
    Pediatric Research, 2012, 71 : 210 - 214